Mingjiang Xu, MD, PhD, professor of molecular medicine, was awarded a $1 million UT System Faculty STARs award to enhance cancer epigenetics research and support the discovery of targeted therapeutics for blood cancers.
Daruka Mahadevan, MD, Ph.D., professor and chief of the Division of Hematology-Oncology in the Long School of Medicine, has studied this progression for 20 years. In a paper published in April 2020 in the journal Trends in Cancer, he and co-author Gregory C. Rogers, Ph.D., explain a rationale for stopping it.
The Cancer Prevention and Research Institute of Texas awarded more than $10.3 million Aug. 19 to the Mays Cancer Center, home to UT Health San Antonio MD Anderson. The five grants include $6 million to recruit David Gius, MD, PhD, a breast cancer and radiation oncology researcher from the Robert H. Lurie Comprehensive Cancer Center at Northwestern University.